Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Advances in Radiation Oncology
|
December 6, 2017
Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408
R Charles Nichols, Chen Hu, Jean-Paul Bahary, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 7, 2007
Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach
K S Clifford Chao, Shreerang Bhide, Hansen Chen, et al.
Journal of Neuro-Oncology
|
October 30, 2015
CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933
Chip Caine, Snehal Deshmukh, Vinai Gondi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2014
Institutional clinical trial accrual volume and survival of patients with head and neck cancer
Evan J Wuthrick, Qiang Zhang, Mitchell Machtay, et al.
JAMA Oncology
|
July 9, 2017
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial
Mohan Suntharalingam, Kathryn Winter, David Ilson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 6, 2021
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)
Juanita Crook, Joseph P Rodgers, Thomas M Pisansky, et al.
European Urology
|
September 13, 2015
Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08
Justin C Voog, Rebecca Paulus, William U Shipley, et al.
JAMA Network Open
|
June 2, 2023
Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial
Nancy Y Lee, Jonathan Harris, John Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2014
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity
Phuc Felix Nguyen-Tan, Qiang Zhang, K Kian Ang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2016
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129
Canhua Xiao, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Advances in Radiation Oncology
|
December 6, 2017
Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408
R Charles Nichols, Chen Hu, Jean-Paul Bahary, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 7, 2007
Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach
K S Clifford Chao, Shreerang Bhide, Hansen Chen, et al.
Journal of Neuro-Oncology
|
October 30, 2015
CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933
Chip Caine, Snehal Deshmukh, Vinai Gondi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2014
Institutional clinical trial accrual volume and survival of patients with head and neck cancer
Evan J Wuthrick, Qiang Zhang, Mitchell Machtay, et al.
JAMA Oncology
|
July 9, 2017
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial
Mohan Suntharalingam, Kathryn Winter, David Ilson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 6, 2021
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)
Juanita Crook, Joseph P Rodgers, Thomas M Pisansky, et al.
European Urology
|
September 13, 2015
Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08
Justin C Voog, Rebecca Paulus, William U Shipley, et al.
JAMA Network Open
|
June 2, 2023
Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial
Nancy Y Lee, Jonathan Harris, John Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2014
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity
Phuc Felix Nguyen-Tan, Qiang Zhang, K Kian Ang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2016
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129
Canhua Xiao, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
Page
of 5